Insufficient scRNA-seq data for expression of HSD3B7 at single-cell level.
Insufficient scRNA-seq data for expression of HSD3B7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4075.25 | 226 / 226 | 100% | 61.92 | 405 / 406 |
breast | 100% | 812.29 | 459 / 459 | 98% | 30.80 | 1092 / 1118 |
intestine | 100% | 723.89 | 966 / 966 | 97% | 25.14 | 513 / 527 |
stomach | 100% | 403.92 | 358 / 359 | 98% | 27.84 | 279 / 286 |
ovary | 99% | 372.10 | 179 / 180 | 97% | 25.87 | 419 / 430 |
pancreas | 100% | 678.13 | 328 / 328 | 96% | 27.16 | 171 / 178 |
lung | 99% | 550.89 | 574 / 578 | 96% | 20.57 | 1111 / 1155 |
esophagus | 100% | 628.75 | 1443 / 1445 | 95% | 20.03 | 174 / 183 |
kidney | 100% | 1289.85 | 89 / 89 | 94% | 66.88 | 846 / 901 |
uterus | 100% | 466.24 | 170 / 170 | 93% | 20.80 | 428 / 459 |
prostate | 99% | 464.68 | 243 / 245 | 94% | 14.84 | 471 / 502 |
skin | 100% | 841.40 | 1809 / 1809 | 86% | 19.86 | 408 / 472 |
bladder | 100% | 703.48 | 21 / 21 | 84% | 17.06 | 424 / 504 |
thymus | 97% | 330.14 | 635 / 653 | 80% | 10.54 | 486 / 605 |
adrenal gland | 100% | 1149.66 | 258 / 258 | 41% | 7.21 | 94 / 230 |
brain | 69% | 153.42 | 1830 / 2642 | 42% | 5.23 | 295 / 705 |
adipose | 100% | 1082.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 840.97 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.83 | 1 / 1 |
blood vessel | 94% | 403.62 | 1253 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 17.34 | 42 / 45 |
heart | 91% | 273.26 | 787 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 13.33 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 83% | 9.76 | 66 / 80 |
muscle | 57% | 144.20 | 461 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 176.03 | 452 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0035754 | Biological process | B cell chemotaxis |
GO_0005811 | Cellular component | lipid droplet |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003854 | Molecular function | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity |
GO_0047016 | Molecular function | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016616 | Molecular function | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
Gene name | HSD3B7 |
Protein name | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) |
Synonyms | |
Description | FUNCTION: The 3-beta-HSD enzymatic system plays a crucial role in the biosynthesis of all classes of hormonal steroids. HSD VII is active against four 7-alpha-hydroxylated sterols. Does not metabolize several different C(19/21) steroids as substrates. Involved in bile acid synthesis . Plays a key role in cell positioning and movement in lymphoid tissues by mediating degradation of 7-alpha,25-dihydroxycholesterol (7-alpha,25-OHC): 7-alpha,25-OHC acts as a ligand for the G protein-coupled receptor GPR183/EBI2, a chemotactic receptor for a number of lymphoid cells (By similarity). . |
Accessions | I3L2H6 ENST00000297679.10 [Q9H2F3-1] ENST00000562932.5 ENST00000574447.1 ENST00000262520.10 [Q9H2F3-2] I3L2Q9 Q9H2F3 |